Up and up Anticavity Toothpaste Whitening

Description

The product is an anticavity fluoride rinse identified by SPL Code 34089-3. It contains sodium fluoride as the active ingredient at a concentration of 0.05% (0.02% w/v). The formulation is presented as a clear, colorless liquid. Inactive ingredients include water, glycerin, sorbitol, flavor, sodium benzoate, citric acid, sodium saccharin, and ethanol.

Uses and Indications

This drug is indicated for the protection against dental cavities.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects reported.

Dosage and Administration

Adults and children aged 2 years and older are advised to brush their teeth thoroughly, preferably after each meal, or at least twice daily, or as directed by a dentist. It is important to ensure that the product is not swallowed during the brushing process.

For children under 6 years of age, a pea-sized amount of the product should be used to minimize the risk of swallowing. Caregivers should supervise the brushing process until proper oral hygiene habits are established.

For children under 2 years of age, it is recommended to consult a dentist or physician for guidance on appropriate use.

Contraindications

There are no contraindications listed for this product. It is important to evaluate individual patient circumstances and consult relevant clinical guidelines when considering its use.

Warnings and Precautions

It is imperative to keep fluoride toothpaste out of the reach of children under 6 years of age. Accidental ingestion of amounts greater than what is typically used for brushing can pose serious health risks. In such cases, it is crucial to seek professional medical assistance or contact a Poison Control Center immediately to ensure appropriate management and care.

Healthcare professionals should remain vigilant regarding the potential for fluoride toxicity in young children and educate caregivers on the importance of supervising the use of fluoride-containing products. Regular monitoring and guidance can help mitigate risks associated with accidental ingestion.

Side Effects

Patients should be aware of the potential risks associated with the use of fluoride toothpaste. As with all fluoride-containing products, it is crucial to keep the toothpaste out of reach of children under 6 years of age. Accidental ingestion of amounts greater than what is typically used for brushing may lead to serious health concerns. In such cases, it is imperative to seek professional medical assistance or contact a Poison Control Center immediately.

These precautions are essential to ensure the safety of young children, as they may be more susceptible to the adverse effects of fluoride.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Up and up Anticavity Toothpaste Whitening (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should be kept out of reach of the product. In the event of accidental ingestion exceeding the amount used for brushing, it is imperative to seek professional assistance or contact a Poison Control Center immediately.

For children aged 2 years and older, it is recommended to brush teeth thoroughly, preferably after each meal or at least twice daily, or as directed by a dentist. Care should be taken to avoid swallowing the product. For children under 6 years, a pea-sized amount should be used to minimize swallowing, and adult supervision during brushing is advised until proper oral hygiene habits are established.

For infants and children under 2 years, consultation with a dentist or physician is recommended prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There is no specific information regarding the use of Up and Up Anticavity Toothpaste Whitening in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider this lack of data when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data regarding its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative that healthcare professionals take immediate action. If a patient accidentally ingests more than the recommended amount used for brushing, it is crucial to seek professional assistance without delay.

Healthcare providers should advise the patient or caregiver to contact a Poison Control Center immediately for guidance on the appropriate steps to take. Prompt intervention is essential to mitigate potential adverse effects associated with overdosage.

Monitoring for symptoms related to overdosage is also important, although specific symptoms were not detailed in the provided information. Therefore, healthcare professionals should remain vigilant and assess the patient for any unusual signs or reactions following an overdosage incident.

In summary, immediate professional help and contact with a Poison Control Center are the recommended actions in the case of overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the potential risks associated with children accessing the medication, including serious health consequences. Providers should encourage patients to store the medication in a secure location and to be vigilant about monitoring its use.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and effectiveness. Additionally, the product should be kept out of reach of children to ensure safety during storage and handling.

Additional Clinical Information

The product is administered via the dental route. Clinicians should advise patients to keep the product out of reach of children under 6 years of age. In the event of accidental ingestion of more than the amount used for brushing, patients should seek professional help or contact a Poison Control Center immediately. To minimize the risk of swallowing, it is recommended to use a pea-sized amount and supervise brushing until proper habits are established. For children under 2 years of age, consultation with a dentist or physician is advised.

Drug Information (PDF)

This file contains official product information for Up and up Anticavity Toothpaste Whitening, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)